Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.66B | 1.89B | 1.42B | 1.30B | 1.01B |
Gross Profit | 1.03B | 983.25M | 689.31M | 548.97M | 584.68M |
EBITDA | 441.90M | 445.34M | 211.63M | 175.08M | 255.04M |
Net Income | 75.60M | 40.82M | 31.78M | 62.25M | 159.25M |
Balance Sheet | |||||
Total Assets | 6.37B | 5.32B | 4.26B | 3.86B | 3.04B |
Cash, Cash Equivalents and Short-Term Investments | 112.10M | 137.92M | 70.95M | 129.67M | 183.60M |
Total Debt | 2.47B | 2.33B | 1.39B | 1.16B | 872.71M |
Total Liabilities | 3.56B | 3.05B | 2.00B | 2.26B | 1.74B |
Stockholders Equity | 2.81B | 2.27B | 2.26B | 1.60B | 1.30B |
Cash Flow | |||||
Free Cash Flow | -457.10M | -685.02M | -861.17M | -457.73M | -235.56M |
Operating Cash Flow | 478.70M | -27.22M | -378.15M | -47.02M | 6.61M |
Investing Cash Flow | -885.60M | -648.60M | -527.80M | -388.15M | -233.58M |
Financing Cash Flow | 246.70M | 415.13M | 716.39M | 455.27M | 300.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ₹8.38B | 30.03 | 0.30% | 44.95% | 184.04% | ||
69 Neutral | ₹8.36B | 32.80 | ― | -7.67% | 36.60% | ||
67 Neutral | ₹8.74B | 22.60 | 0.38% | -3.77% | -9.20% | ||
59 Neutral | kr30.17B | 0.02 | -5.14% | 3.50% | 2.33% | -25.14% | |
54 Neutral | ₹2.11B | 44.29 | 2.30% | -15.63% | 0.14% | ||
52 Neutral | ₹8.73B | 29.89 | 0.17% | 19.75% | 844.66% | ||
43 Neutral | ₹690.23M | 0.29 | ― | -51.79% | ― |
Sadhana Nitro Chem Limited’s board meeting on May 2, 2025, resulted in several significant decisions. The board approved the audited financial results for the quarter and year ending March 31, 2025, and recommended a 10% dividend for the financial year 2024-25. Additionally, the company appointed new auditors for internal, cost, and secretarial audits for the financial year 2025-26, and confirmed the re-appointment of its statutory auditor. The board also noted the utilization of proceeds from a recent rights issue, indicating a strategic focus on financial transparency and accountability.
Sadhana Nitro Chem Limited’s Board of Directors approved the audited financial results for the quarter and year ending March 31, 2025, and recommended a 10% dividend per equity share. The Board also appointed new auditors for internal, cost, and secretarial audits for the financial year 2025-26, and noted the utilization of proceeds from a recent rights issue.